|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Product revenue | |||||
| License revenue | |||||
| Other revenue | |||||
| Revenues | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Impairment loss | |||||
| Research and development expenses | |||||
| Selling, general and administrative expenses (related party of $450,000 and $1,116,064) | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Income from legal claims | |||||
| Other income (expense) | |||||
| Income from legal claims | |||||
| Interest expense (related party of $nil and $245,724) | |||||
| Loss on change in fair value of profit share | |||||
| Loss on investment | |||||
| Gain on extinguishment of debt | |||||
| Loss on change in fair value of profit share and unsecured note | |||||
| Interest income | |||||
| Total other (expense) income | |||||
| Loss before provision for income taxes | |||||
| Income tax benefit (expense) | |||||
| Basic net (loss) income per share | |||||
| Net loss | |||||
| Basic & Diluted loss per share: | |||||
| Basic and diluted net loss per share | |||||
| Basic | |||||
| Diluted | |||||
Loading...